Menthol, Inflammation, and Nicotine Transition Study
NCT06232447
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cigarette Smoking
- Inflammatory Response
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Rosalind Franklin University of Medicine and Science
- Last updated on ClinicalTrials.gov
- April 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Rosalind Franklin University of Medicine and Science · North Chicago, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.